Embolectomy for stroke with emergent large vessel occlusion (ELVO): report of the Standards and Guidelines Committee of the Society of NeuroInterventional Surgery: Table 1
| Autor: | Josser A Delgado-Almandoz, Robert W Tarr, Don Heck, Michael J. Alexander, Mahesh V Jayaraman, Michael Kelly, Philip M. Meyers, Robert M. Starke, Don Frei, Seon Kyu Lee, Adam S Arthur, Ketan R. Bulsara, Barbara Albani, T. M. Leslie-Mawzi, Peter A. Rasmussen, Michael Chen, G. Lee Pride, Blaise Baxter, Steven W. Hetts, Todd Abruzzo, Ryan A McTaggart, Sameer A. Ansari, M. Shazam Hussain, Charles J. Prestigiacomo, Felipe C. Albuquerque, Justin F. Fraser, Athos Patsalides |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
business.industry medicine.medical_treatment Embolectomy General Medicine Thrombolysis Evidence-based medicine medicine.disease Surgery Natural history medicine.artery Middle cerebral artery Occlusion medicine Neurology (clinical) Internal carotid artery Intensive care medicine business Stroke |
| Zdroj: | Journal of NeuroInterventional Surgery. 7:316-321 |
| ISSN: | 1759-8486 1759-8478 |
| DOI: | 10.1136/neurintsurg-2015-011717 |
| Popis: | Stroke is the leading cause of adult disability in North America and is the fifth most common cause of death.1 ,2 The natural history of patients with acute ischemic stroke and occlusion of a major intracranial vessel such as the internal carotid artery (ICA), middle cerebral artery (MCA), or basilar artery is dismal, with high rates of mortality and low rates of disability-free survival.3 ,4 We introduce the term ‘Emergent Large Vessel Occlusion (ELVO)’ to describe this clinical scenario. Among acute ischemic stroke, ELVO accounts for the greatest proportion of patients with long-term disability. For the past two decades the use of endovascular therapy has been performed in many centers across the world. The therapies have spanned from infusion of thrombolytic agents5 ,6 to mechanical embolectomy with the introduction of first-generation devices,7 ,8 aspiration-based embolectomy techniques,9 ,10 and the use of stent-retriever based procedures.11 ,12 However, these embolectomy trials were single-arm trials demonstrating safety of the procedure and technique or superiority over another, without direct comparison with standard medical therapy alone. In the past 3 years, several major trials have been published comparing endovascular therapy with standard medical therapy alone. The purpose of this document is to summarize the results of these trials and synthesize the level of evidence supporting the use of embolectomy in patients with ELVO. This document was prepared by the Standards and Guidelines Committee of the Society of NeuroInterventional Surgery, a multidisciplinary society representing the leaders in the field of endovascular therapy for neurovascular disease. The strength of the evidence supporting each recommendation was summarized using a scale previously described by the American Heart Association. ### Role of intravenous thrombolysis In 1996 the FDA approved the use of recombinant tissue plasminogen activator (tPA) for the treatment of acute ischemic stroke … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|